Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

INTRODUCTION: Netarsudil reduces intraocular pressure (IOP) by increasing aqueous outflow through the trabecular meshwork (TM) pathway and decreasing episcleral venous pressure. The primary objective of this phase 2 study was to evaluate ocular hypotensive efficacy and safety of three netarsudil con...

Descripción completa

Detalles Bibliográficos
Autores principales: Araie, Makoto, Sugiyama, Kazuhisa, Aso, Kenji, Kanemoto, Koji, Kothapalli, Kalyani, Kopczynski, Casey, Senchyna, Michelle, Hollander, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004483/
https://www.ncbi.nlm.nih.gov/pubmed/33629227
http://dx.doi.org/10.1007/s12325-021-01634-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004483/
https://www.ncbi.nlm.nih.gov/pubmed/33629227
http://dx.doi.org/10.1007/s12325-021-01634-9

Ejemplares similares